ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281817; 2) Community: the network communities that were significantly associated with the response to NSC 281817; 3) Molecule: the relationships between components within communities and NSC 281817; 4) MDR: the compounds that were significantly associated with the NSC 281817.

NSC Compound Enrichment Correlation
NSC 336003 Olivacinium acetate-NB methyl RB 544 0.0339770934764516 -0.06400951
NSC 356777 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1-hydroxy-7-oxo- 1,3,5-cycloheptriene-2-yl)- 0.0339770934764516 0.2353338
NSC 56902 Null 0.0339770934764516 0.099836703
NSC 626669 Null 0.0339770934764516 -0.15452068
NSC 631304 cis-Amminedichloro[2-(3,4-dimethoxyphenyl)ethylamine] platinum(II) 0.0339770934764516 0.2298176
NSC 639366 1-[[3'-(Diethylamino)-2'-hydroxypropyl]amino]-4- [(2'',3''-epoxypropyl)-amino-9,10-anthracenedione Fumaric Acid 0.0339770934764516 0.089903684
NSC 671135 Null 0.0339770934764516 0.036217221
NSC 681644 Camptothecin Derivative 0.0339770934764516 0.52884145
NSC 682306 N-[p-[N-(2,4,7-triamino-6-pteriddinylmethyl)-N-methylamino]benzoyl]glutamic acid 0.0339770934764516 0.33175815
NSC 683557 Camptothecin Derivative 0.0339770934764516 0.4712724
Total:66  Current:42    [First] [Prev] [Next] [Last]